Analysis of low-abundant gut hormone peptides using mass spectrometry

In this video, Dr. Richard Kay, Senior Research Associate at the Wellcome Trust MRC Institute of Metabolic Science at Cambridge University, talks about how he uses mass spectrometry to measure gut hormone peptides related to diabetes. Kay outlines the challenges of detecting low-abundant peptides such as insulin and explains the benefits of performing peptide mass spectrometry over immunoassays.